Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens

• Published in: Antibiotics
• Main Authors: Marco Artini, Rosanna Papa, Gianluca Vrenna, Marika Trecca, Irene Paris, Caterina D’Angelo, Maria Luisa Tutino, Ermenegilda Parrilli, Laura Selan
• Other Authors: Artini, Marco, Papa, Rosanna, Vrenna, Gianluca, Trecca, Marika, Paris, Irene, D’Angelo, Caterina, Tutino, MARIA LUISA, Parrilli, Ermenegilda, Selan, Laura
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2023
• Subjects: Acinetobacter baumannii; Enterobacter sp; Enterococcus faecium; Klebsiella pneumoniae; Pseudomonas aeruginosa; Staphylococcus aureu; biofilm; Antarctic; Antarc*
• Online Access: https://hdl.handle.net/11588/944883; https://doi.org/10.3390/antibiotics12101556

: The ESKAPE pathogens, including bacteria such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, pose a global health threat due to their ability to resist antimicrobial drugs and evade the immune system. These pathogens are responsible for hospital-acquired infections, especially in intensive care units, and contribute to the growing problem of multi-drug resistance. In this study, researchers focused on exploring the potential of Antarctic marine bacteria as a source of anti-biofilm molecules to combat ESKAPE pathogens. Four Antarctic bacterial strains were selected, and their cell-free supernatants were tested against 60 clinical ESKAPE isolates. The results showed that the supernatants did not exhibit antimicrobial activity but effectively prevented biofilm formation and dispersed mature biofilms. This research highlights the promising potential of Antarctic bacteria in producing compounds that can counteract biofilms formed by clinically significant bacterial species. These findings contribute to the development of new strategies for preventing and controlling infections caused by ESKAPE pathogens.